服用佩拉曼尼尔的耐药性患者的睡眠影响:一项观察性研究
Fabio Lamanna1, Orazio Pardeo1, Diana Tilenni1
1Neurophysiopatology and Movement Disorders Clinic, University of Messina, Messina, Italy.
概括
珀兰 (PER) 改善了耐火性患者的睡眠质量和生活质量. 作为第一个附加疗法,PER显示出更高的疗效,表现出良好的耐受性.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 佩拉曼奈尔 (PER) 是一种AMPA受体对抗剂.
- 关于PER对睡眠质量影响的研究有限.
- 这项研究评估了PER对耐性患者睡眠的影响.
研究的目的:
- 评估Perampanel对睡眠质量的影响.
- 评估Perampanel对白天嗜睡和生活质量的影响.
- 为了比较Perampanel的疗效作为第一个和后来的补充疗法.
主要方法:
- 31名耐火性患者接受了Perampanel (PER) 作为附加疗法.
- 评估了睡眠质量 (PSQI),白天嗜睡 (ESS) 和生活质量 (QOLIE-31).
- 通过减少发作来衡量有效性;通过不良事件来衡量耐受性.
主要成果:
- 睡眠质量和白天的嗜睡程度略有改善.
- 生活质量略有改善;在晚期补充患者中,发作的担忧显著减少.
- PER耐受性良好;当作为第一个附加疗法使用时,观察到更高的疗效 (p=0.043).
结论:
- 佩拉曼奈尔 (PER) 可能保持睡眠质量并改善生活质量.
- 作为抗药性的初始补充治疗,PER显示出卓越的疗效.
- PER是一种耐受性良好的选择,用于治疗耐火性.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
624
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
624
Sedatives and Hypnotics Drugs: Miscellaneous Agents
502
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
502
Antiepileptic Drugs: Glutamate Antagonists
884
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
884
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
630
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
630


